Current Infectious Disease Reports

, Volume 14, Issue 3, pp 213–226 | Cite as

NDM-1 and the Role of Travel in Its Dissemination

  • Mary Elizabeth WilsonEmail author
  • Lin H. Chen
Tropical and Travel Medicine (LH Chen, Section Editor)


Antimicrobial resistance is a growing problem globally. The appearance and spread of bacteria that are resistant to most or all commonly available antibiotics has raised the specter of untreatable bacterial infections. The New Delhi metallo-beta-lactamase-1 (NDM-1) has received wide attention because of the extreme resistance it confers, its presence in many common pathogens, its rapid spread to multiple continents, and local nosocomial spread in some areas. Most early reports of infections were in individuals who had received medical care in the Indian subcontinent. This paper will explore the role of travelers in the movement of pathogens and microbial genetic material associated with resistance, with a special focus on the appearance and dispersal of bacteria carrying this mobile genetic element, bla NDM-1, and the contributing factors, including growing long-distance travel and expansion of travel across international borders for medical, dental, and surgical care (medical tourism).


NDM-1 Antimicrobial resistance Carbapenemase Metallo-beta-lactamases Medical tourism Antibiotic resistance ESBL (extended spectrum beta-lactamases) Beta-lactamases New Delhi beta-lactamase Multidrug resistance Carbapenems CTX Gram-negatives Resistome Lateral genetic transfer Mobile genetic elements blaNDM-1 



Dr. M. E. Wilson has been a board member for BSC (CDC); icddrb, has received payment for lectures from the International Society of Travel Medicine, payment for writing summaries from JWID, royalties from Up-To-Date, and travel and accommodation support from IDSA for lecture. Dr. L. Chen reported no potential conflicts of interest relevant to this article.


Papers of Particular Interest, Published Recently, Have Been Highlighted As: • Of importance •• Of major Importance

  1. 1.•
    Yong D, Toleman MA, Giske CG, et al.: Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53(12):5046–54. Paper describes the first patient documented to be infected with NDM-1; characterizes the new metallo-beta-lactamase. Google Scholar
  2. 2.••
    Kumarasamy KK, Toleman MA, Walsh TR, et al.: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602. Authors identified NDM-1-positive isolates from India, Pakistan, and the UK. Many of the source patients in had traveled to India or Pakistan. Isolates were multidrug-resistant; resistance on plasmids transferred readily to other Enterobacteriaceae. Google Scholar
  3. 3.••
    Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–8. Authors review different classes of beta-lactamases. They summarize the global spread of global spread of NDM-1 producing bacteria. Google Scholar
  4. 4.
    Chen L, Wilson ME. The role of the traveler in emerging infections and magnitude of travel. Med Clin N Amer. 2008;92:1409–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Reed CM. Medical tourism. Med Clin N America. 2008;92:1433–46.PubMedCrossRefGoogle Scholar
  6. 6.
    Wilson ME. The traveler and emerging infectious diseases: sentinel, courier, transmitter. J Appl Microbiol. 2003;94:1S–11S.PubMedCrossRefGoogle Scholar
  7. 7.
    Walsh TR, Toleman MA, Sarma JB, et al. New Delhi metallo-β-lactamase 1 – authors reply. Letter Lancet Infect Dis. 2010;10:752–4.CrossRefGoogle Scholar
  8. 8.
    Birgy A, Doit C, Mariani-Kurkdjian P, et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol. 2011;49(8):3085–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Bogaerts P, Bouchahrouf W, Rezende R, et al. Emergence of NDM-1-producing Enterobacteriaceae in Belgium. Antimicrob Agents Chemother. 2011;55(6):3036–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Brink AJ, Coetzee J, Clay CG, et al.: Emergence of New Delhi metallo-beta-lactamase (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC-2) in South Africa. J Clin Microbiol. 2011; E-pub ahead of print.Google Scholar
  11. 11.••
    Castanheira M, Deshpande LM, Mathai D, et al.: Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011;55(3):1274–8. Authors document that NDM-1 producing isolates were disseminated in Indian health care facilities as early as 2006. Google Scholar
  12. 12.
    Centers for Disease Control and Prevention (CDC). Detection of Enterobacteriaceae isolates carrying metallo-β-lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59(24):750.Google Scholar
  13. 13.
    Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66(6):1255–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Chihara S, Okuzumi K, Yamamoto Y, et al. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan. Clin Infect Dis. 2011;52(1):153–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Chu Y-W, Tung VMN, Cheung TKM, et al. Carbapenemases in enterobacteria, Hong Kong, China, 2000. Emerg Infect Dis. 2011;17(1):130–2.PubMedCrossRefGoogle Scholar
  16. 16.
    D’Andrea MM, Venturelli C, Giani T, et al. Persistent carriage and infection by multi-drug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases. J Clin Microbiol. 2011;49(7):2755–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Deshpande P, Shetty A, Kapadia F, et al. New Delhi metallo 1: have carbapenems met their doom? Clin Infect Dis. 2010;51(10):1222.PubMedCrossRefGoogle Scholar
  18. 18.
    Espinal P, Fugazza G, Lopez Y, et al. Dissemination of a NDM-2 producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemo. 2011;55:5396–8.CrossRefGoogle Scholar
  19. 19.
    Gaibani P, Ambretti S, Berlingeri A, et al.. Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. Eurosurveillance. 2011;24;16(47).
  20. 20.
    Gecaj-Gashi A, Hasani A, Bruqi B, Milliqi-Osmani G. Balkan NDM-1: escape or transplant? Lancet Infect Dis. 2011;11:586.PubMedCrossRefGoogle Scholar
  21. 21.
    Ghazawi A, Sonnevend A, Bonnin RA, et al.. NDM-2-carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect. 2011; doi:  10.1111/j.1469-0691.2011.03726.x. E-pub ahead of print
  22. 22.
    Göttig S, Pfeifer Y, Wichelhaus TA, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10(12):828–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Hammerum AM, Toleman MA, Hansen F, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10(12):829–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother. 2011;55(12):5952–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Jamal W, Rotimi VO, Albert MJ, et al.. Emergence of nosocomial New Delhi metallo-β-lactamase (NDM-1) producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait. Letter. International J Antimicrob Agents 2011; E-pub ahead of printGoogle Scholar
  26. 26.
    Jovic B, Lepsanovic Z, Suljagic V, et al. Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011;55(8):3929–31.CrossRefGoogle Scholar
  27. 27.
    Kaase M, Nordmann P, Wichelhaus TA, et al. NDM-2-carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011;66:1260–2.PubMedCrossRefGoogle Scholar
  28. 28.
    Koh TH, Khoo CT, Wijaya L, et al. Global spread of New Delhi metallo-β-lactamase-1. Lancet Infect Dis. 2010;10(12):828.PubMedCrossRefGoogle Scholar
  29. 29.
    Lascols C, Hacket M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-B-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother. 2011;66:1992–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Leverstein-Van Hall MA, Stuart JC, Voets GM, et al. Global spread of New Delhi metallo-β-lactamase-1. Lancet Infect Dis. 2010;10(12):830–1.PubMedCrossRefGoogle Scholar
  31. 31.
    Mochon AB, Garner OB, Hindler JA, et al. New Delhi metallo- β-Lactamase (NDM-1)-producing Klebsiella pneumoniae: Case report and laboratory detection strategies. J Clin Microbiol. 2011;49(4):1667–70.PubMedCrossRefGoogle Scholar
  32. 32.
    Muir A, Weinbren JM. New Delhi metallo-β-lactamase: a cautionary tale. J Hospital Infect. 2010;75:239–40.CrossRefGoogle Scholar
  33. 33.
    Mulvey MR, Grant JM, Plewes K, et al. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis. 2011;17(1):103–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Nordmann P, Couard J-P, Sansot D, Poirel L. Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clin Infect Dis. 2012;54(1):150–1.PubMedCrossRefGoogle Scholar
  35. 35.
    Peirano G, Ahmed-Bentley J, Woodford N, Pitout JD. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis. 2011;17(2):242–4.PubMedGoogle Scholar
  36. 36.
    Peirano G, Pillai DR, Pitondo-Silva A, et al. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diag Microbiol Infect Dis. 2011;71:106–9.CrossRefGoogle Scholar
  37. 37.••
    Perry JD, Naqvi SH, Mirza IA, et al.. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother. 2011;66(10):2288–94. Authors find that outpatients also carry NDM-1 producing bacteria in fecal flora. They assess the performance characteristics of two tests to screen for NDM-1 producing bacteria.Google Scholar
  38. 38.
    Pfeifer Y, Witte W, Holfelder M, et al. NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother. 2011;55(3):1318–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Poirel L, Al Maskari Z, Al Rashdi F, et al. NDM-1-producing Klebsiella pneumoniae isolated in the Sultanate of Oman. J Antimicrob Chemother. 2011;66(2):304–6.PubMedCrossRefGoogle Scholar
  40. 40.
    Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. J Antimicrob Chemother. 2011;66(12):2781–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Poirel L, Fortineau N, Nordmann P. International Transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob Agents Chemother. 2011;55(4):1821–2.PubMedCrossRefGoogle Scholar
  42. 42.
    Poirel L, Hombrouck-Alet C, Freneaux C, et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis. 2010;10(12):832.PubMedCrossRefGoogle Scholar
  43. 43.
    Poirel L, Lagrutta E, Taylor P, et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother. 2010;54(11):4914–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Poirel L, Lascols C, Bernabeu S, Nordmann P. NDM-1-producing Klebsiella pneumoniae in Mauritius. Antimicrob Agents Chemother. 2012;56(1):598–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Poirel L, Revathi G, Bernabeu S, Nordmann P. Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother. 2011;55(2):934–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Poirel L, Ros A, Carricajo A, et al. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother. 2011;55(1):447–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Poirel L, Schrenzel J, Cherkaoui A, et al.: Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J Antimicrob Chemother. 2011;66(8):1730–3.PubMedCrossRefGoogle Scholar
  48. 48.
    Potron A, Poirel L, Verdavaine D, Nordmann P. Importation of KPC-producing Escherichia coli from India. J Antimicrob Chemother 2012;doi:  jac/jac/dkr426. 3 Oct 2011. E-pub ahead of print
  49. 49.
    Roy S, Singh AK, Viswanathan R, et al. Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. J Antimicrob Chemother. 2011;66:2773–80.PubMedCrossRefGoogle Scholar
  50. 50.
    Samuelsen O, Thilesen CM, Heggelund L, et al. Identification of NDM-1-producing Enterobacteriaceae in Norway. J Antimicrob Chemother. 2011;66(3):670–2.PubMedCrossRefGoogle Scholar
  51. 51.
    Savard P, Gopinath R, Zhu W, et al.. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother. 2011;55(12):5957–8.Google Scholar
  52. 52.
    Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis. 2011;52(4):481–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Sole M, Pitart C, Roca I, et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother. 2011;55(9):4402–4.PubMedCrossRefGoogle Scholar
  54. 54.
    Tijet N, Alexander DC, Richardson D, et al. New Delhi metallo-beta-lactamase, Ontario, Canada. Emerg Infect Dis. 2011;17(2):306–7.PubMedGoogle Scholar
  55. 55.
    Wu HS, Chen TL, Chen IC, et al. First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. J Chin Med Assoc. 2010;73(11):596–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Zarfel G, Hoenigl M, Leitner E, et al. Emergence of New Delhi metallo-β-lactamase, Austria. Emerg Infect Dis. 2011;17(1):129–30.PubMedCrossRefGoogle Scholar
  57. 57.•
    Struelens MJ, Monnet DL, Magiorakos AP, et al.. European NDM-1 Survey Participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill. 2010;15(46). Available online at Authors provide excellent summary of cases in Europe. Survey shows that guidelines are not available in many countries for detection and management of patients with NDM-1-producing bacteria.
  58. 58.
    ProMED. Gram negative bacilli, multidrug resistant -South Africa: NDM-1, nosocomial. Posted 18 Oct 2011.Google Scholar
  59. 59.
    Roy S, Viswanathan R, Singh AK, et al. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India. J Antimicrob Chemo. 2011;66(6):1411–3.CrossRefGoogle Scholar
  60. 60.
    Livermore DM, Walsh TR, Toleman M, Woodford N. Balkan NDM-1: escape or transplant? Lancet Infect Dis. 2011;11:164.PubMedCrossRefGoogle Scholar
  61. 61.
    Ivanovski N, Masin J, Rambabova-Busljetic I, et al. The outcome of commercial kidney transplant tourism in Pakistan. Clin Transplant. 2011;25:171–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Poirel L, Hervé V, Hombrouck-Alet C, Nordmann P. Long-term carriage of NDM-1-producing Escherichia coli. J Antimicrob Chemother. 2011;66(9):2185–6.PubMedCrossRefGoogle Scholar
  63. 63.••
    Castanheira M, Mendes RE, Woosley LN, Jones RN. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. From Europe and the Americas: report from the SENTRY antimicrobial surveillance programs (2007–09). Letter. J Antimicrob Chemother 2011. doi: 10.1093/jac/dkr081. Advance access publication 18 March 2011. Broad survey of isolates from multiple countries documents early presence in India and absence in other countries.
  64. 64.
    Huang T-D, Bogaerts P, Berhin C, et al.. Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium. Euro Surveill. 2011;16(26): Available online at
  65. 65.
    Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, the SMART India Working Group. Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospital during 2008. J Med Microbiol. 2010;59:1050–4.PubMedCrossRefGoogle Scholar
  66. 66.•
    Deshpande R, Rodrigues C, Shetty A, et al.. New Delhi metallo-β-lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India. 2010;58:147–9. Authors document that NDM-1-producing bacteria are common in some Indian hospitals.Google Scholar
  67. 67.
    Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother. 2011;66(4):689–92.PubMedCrossRefGoogle Scholar
  68. 68.
    Seema K, Sen MR, Upadhyay S, Bhattacharjee A. Dissemination of the New Delhi metallo-β-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in northern India. J Antimicrob Chemother. 2011;66(7):1646–7.PubMedCrossRefGoogle Scholar
  69. 69.••
    Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355–62. Authors document that NDM-1-producing bacteria can be found in water samples, including tap water, from central New Delhi and are present in many bacterial species, including Vibrio cholerae. They show that transfer of resistance is most efficient at 30º C. Google Scholar
  70. 70.••
    Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol. 2011;19(12):588–95. Authors provide a current review. Google Scholar
  71. 71.
    Carattoli A, Villa L, Poirel L, et al.. Evolution of IncA/C bla cmy-2 carrying plasmids by acquisition of the blaNDM-1 carbapenemase gene. Antimicrob Agents Chemother E-pub ahead of print 28 Nov 2011Google Scholar
  72. 72.
    Moellering Jr RC. NDM-1–a cause for worldwide concern. N Engl J Med. 2010;363(25):2377–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Livermore DM, Warner M, Mushtaq S, et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents. 2011;37(5):415–9.PubMedCrossRefGoogle Scholar
  74. 74.••
    Bonomo RA. New Delhi metallo-B-lactamase and multidrug resistance: a global SOS? Clin Infect Dis. 2011;52:485–7. Author describes the dire situation with increasing multi-drug resistance. Google Scholar
  75. 75.
    Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother. 2011;55(11):5403–7.PubMedCrossRefGoogle Scholar
  76. 76.
    Mushtaq S, Irfan S, Sarma JB, et al. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother. 2011;66:2002–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Pfeifer Y, Wilharm G, Zander E, et al. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998–2001.PubMedCrossRefGoogle Scholar
  78. 78.••
    Potron A, Poirel L, Nordmann P. Plasmid-mediated transfer of the blaNDM-1 gene in Gram-negative rods. FEMS Microbiol Lett. 2011;324(2):111–6. Investigators study plasmid-mediated transfer of NDM-1 under different conditions and between different types of bacteria. Google Scholar
  79. 79.
    Fuursted K, Scholer L, Hansen F, et al.: Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-β-lactamase-1 (NDM-1). Microbes Infection 2011; E-pub ahead of print.Google Scholar
  80. 80.
    Peirano G, Schreckenberger PC, Pitout JD. Characteristics of NDM-1-producing Escherichia coli that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother. 2011;55(6):2986–8.PubMedCrossRefGoogle Scholar
  81. 81.•
    Ho PL, Lo WU, Yeung MK, et al.. Complete sequencing of a pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS ONE. 2011;6(3):e17989. Investigators find sequences from many different organisms in the plasmid carrying NDM-1. Google Scholar
  82. 82.
    Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob Agents Chemother. 2011;55(9):4224–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Kumarasamy K, Kalyanasundaram A. Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India. J Antimicrob Chemother 2012. doi: 10.1093/jac/dkr431. E-pub ahead of print 11 Oct 2011
  84. 84.
    Naas T, Ergani A, Carrer A, Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother. 2011;55(9):4038–43.PubMedCrossRefGoogle Scholar
  85. 85.
    Nordmann P, Poirel L, Carrër A, et al. How to detect NDM-1 producers. J Clin Microbiol. 2011;49(2):718–21.PubMedCrossRefGoogle Scholar
  86. 86.
    Stokes HW, Gillings MR. Gene flow, mobile genetic elements and the recruitment of antibiotic resistance genes into Gram-negative pathogens. FEMS Microbiol Rev. 2011;35:790–819.PubMedCrossRefGoogle Scholar
  87. 87.•
    Walsh TR, Toleman MA. The emergence of a pan-resistant Gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother 2012;67:1–3. Authors call for global response to multi-drug resistance. Google Scholar
  88. 88.•
    Goel N, Wattal C, Oberoi JK, et al.. Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India. J Antimicrob Chemother 2011;66:1625–30. Authors provide data for one hospital in Delhi and document increasing use of broad spectrum antibiotics. Google Scholar
  89. 89.
    Ghafur AK. An obituary – on the death of antibiotics? J Assoc Physicians India. 2010;58:143–4.PubMedGoogle Scholar
  90. 90.
    Choffnes ER, Relman DA, Mack A. Rapporteurs. Antibiotic resistance: implications for global health and novel intervention strategies. Workshop summary. Forum on Microbial Threats: Institute of Medicine. Washington: The National Academies Press; 2010. p. 496.Google Scholar
  91. 91.
    UN News Centre. Mobile telephones more common that toilets in India, UN report finds. 2010.
  92. 92.
    O’Brien TF, PilarPla MD, Mayer KH, et al. Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. Science. 1985;230:87–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Murray BE, Mathewson JJ, DuPont HL, et al. Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents. Antimicrob Agents Chemother. 1990;34(4):515–8.PubMedGoogle Scholar
  94. 94.••
    Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564–8. This study documents that travelers frequently pick up resistant bacteria during international travel; about a quarter carry them for extended periods (at least 6 months). Google Scholar
  95. 95.
    Peirano G, Laupland KB, Gregson DB, Pitout JDD. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med. 2011;18:299–303.PubMedCrossRefGoogle Scholar
  96. 96.
    UNWTO Tourism Highlights, 2011 Edition. Available from:
  97. 97.
    Milstein A, Smith M. America’s new refugees- seeking affordable health care offshore. N Engl J Med. 2006;355:1637–40.PubMedCrossRefGoogle Scholar
  98. 98.
    Rogers BA, Aminzadeh Z, Hayashhi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53:49–56.PubMedCrossRefGoogle Scholar
  99. 99.
    Shetty P. Medical tourism booms in India, but at what cost? Lancet. 2010;376:671–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Harvard School of Public HealthBostonUSA
  2. 2.WashingtonUSA
  3. 3.Harvard Medical SchoolTravel Medicine Center, Mount Auburn HospitalCambridgeUSA

Personalised recommendations